Skip to content

Compare the effect of methimazole and hydroquinone cream in the treatment of melasma

A comparative study of hydroquinone cream 4% and methimasole cream 5% in melasma patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016041727445N1
Enrollment
25
Registered
2016-04-30
Start date
2015-03-11
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Melasma. Chloasma

Interventions

Intervention 1: Control:Use 4% hydroquinone cream every night for 8 weeks. Intervention 2: Case:The use of methimazole 5% cream every night for 8 weeks.
Treatment - Drugs
Control:Use 4% hydroquinone cream every night for 8 weeks
Case:The use of methimazole 5% cream every night for 8 weeks

Sponsors

Vice chancellor for research, Shahid Beheshti University Skin Research Centerof Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:All the people in the age range of 50-20 years and all topical treatments for at least one month prior to study entry and are cut by a dermatologist examination with Wood's light examination (Wood) disease of epidermal melasma approved exclusion criteria and do not have;All people have informed consent to participate in the scheme. Exclusion criteria:Pregnancy and lactation;There Type of melasma 3Use of any treatment for melasma in the last month;Use of oral contraceptives and hormone therapy and medication have any phototoxic;Past medical history of any thyroid disorders in patients

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Efficasy of methimazole 5%cream in severity of melasma with change in colore. Timepoint: Every 4 Weeks. Method of measurement: MASI Score.;Efficacy of hydroquinone 4%cream in severity of melasma with change in colore. Timepoint: Every 4 weeks. Method of measurement: MASI score.

Secondary

MeasureTime frame
Side effects. Timepoint: Every four weeks. Method of measurement: Ask the patient.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElham Olamaei

Skin Research Centers

elhamolamaei@gmail .com+98 21 2274 1507

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026